Gary B. Kaplan, M.D.
Gary B. Kaplan, M.D.
Boston University School of Medicine; VABHS
Verified email at va.gov - Homepage
Title
Cited by
Cited by
Year
Gabapentin in Bipolar Disorder: a placebo-controlled trial of adjunctive medication.
AC Pande, JG Crockatt, CA Janney, G Tsarouch, JL Werth
Bipolar Disorders 2, 249-255, 2000
386*2000
Dose‐dependent pharmacokinetics and psychomotor effects of caffeine in humans
GB Kaplan, DJ Greenblatt, BL Ehrenberg, JE Goddard, MM Cotreau, ...
The Journal of Clinical Pharmacology 37 (8), 693-703, 1997
3631997
Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled study
HR Kranzler, DR Wesson, L Billot
Alcoholism: Clinical & Experimental Research 28, 1051-9, 2004
1882004
Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment
GB Kaplan, JJ Vasterling, PC Vedak
Behavioural pharmacology 21 (5-6), 427-437, 2010
1792010
Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls
JW Tidey, DJ Rohsenow, GB Kaplan, RM Swift
Drug and alcohol dependence 80 (2), 259-265, 2005
1422005
Use of acupuncture by American physicians
DL Diehl, G Kaplan, I Coulter, D Glik, EL Hurwitz
The Journal of Alternative and Complementary Medicine 3 (2), 119-126, 1997
1301997
Naltrexone's effects on reactivity to alcohol cues among alcoholic men.
DJ Rohsenow, PM Monti, KE Hutchison, RM Swift, SM Colby, GB Kaplan
Journal of abnormal psychology 109 (4), 738, 2000
1192000
The use of cognitive enhancers in animal models of fear extinction
GB Kaplan, KA Moore
Pharmacology Biochemistry and Behavior 99 (2), 217-228, 2011
1052011
Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.
GB Kaplan, DJ Greenblatt, MA Kent, MM Cotreau-Bibbo
Journal of Pharmacology and Experimental Therapeutics 266 (3), 1563-1572, 1993
971993
Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications
GB Kaplan, SC Heinrichs, RJ Carey
Pharmacology Biochemistry and Behavior 97 (3), 619-625, 2011
872011
GABAB receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization
KA Leite-Morris, EY Fukudome, MH Shoeb, GB Kaplan
Journal of Pharmacology and Experimental Therapeutics 308 (2), 667-678, 2004
732004
Relationship of plasma and brain caffeine metabolites to benzodiazepine receptor binding and locomotor activity
GB Kaplan, DJ Greenblatt, BW LeDuc, ML Thompson, RI Shader
Journal of Pharmacology and Experimental Therapeutics 248, 1078-83, 1989
711989
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
JW Tidey, DJ Rohsenow, GB Kaplan, RM Swift, N Reid
Psychopharmacology 217 (2), 279-287, 2011
622011
Baclofen enhances extinction of opiate conditioned place preference
SC Heinrichs, KA Leite-Morris, RJ Carey, GB Kaplan
Behavioural brain research 207 (2), 353-359, 2010
622010
Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions
GB Kaplan, KA Leite-Morris, M Joshi, MH Shoeb, RJ Carey
Brain research 987 (1), 122-125, 2003
622003
Adenosine receptor agonists attenuate and antagonists exacerbate opiate withdrawal signs
GB Kaplan, MT Sears
Psychopharmacology 123, 64-70, 1996
581996
Single‐dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects
GB Kaplan, DJ Greenblatt, BL Ehrenberg, JE Goddard, JS Harmatz, ...
The Journal of Clinical Pharmacology 38 (1), 14-21, 1998
571998
Alterations of adenosine A1 receptors in morphine dependence
GB Kaplan, KA Leite-Morris, MT Sears
Brain research 657 (1-2), 347-350, 1994
561994
Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls
JW Tidey, DJ Rohsenow, GB Kaplan, RM Swift, CG AhnAllen
Nicotine & Tobacco Research 15 (1), 121-129, 2012
552012
Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome
GB Kaplan, NH Bharmal, KA Leite-Morris, WR Adams
Alcohol 19 (2), 157-162, 1999
551999
The system can't perform the operation now. Try again later.
Articles 1–20